Inventaire - your friends and communities are your best library

Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia

Author

Michael Levitt

Published in: Psychiatry Research

Date of publication: October 1, 1982

Language: English

Main subject: schizophrenia, amine oxidase (copper-containing)

Bibliographic databases:

Cites articles 25

Date

Title

Authors

July 1, 1972

Reduced monoamine oxidase activity in blood platelets from schizophrenic patients
March 2, 1973

Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia,Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia
June 1, 1973

Genetic Control of Platelet and Plasma Monoamine Oxidase Activity
January 1, 1974

Dose equivalence of the antipsychotic drugs
January 1, 1975

Reduction of Blood Platelet Monoamine Oxidase Activity in Schizophrenic Patients on Phenothiazines
November 1, 1976

Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity
March 1, 1976

Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients
June 1, 1978

Research diagnostic criteria: rationale and reliability
October 1, 1978

Monoamine oxidase activity in different density gradient fractions of human platelets
December 1, 1978

Schizophrenia in a North Swedish geographical isolate, 1900-1977. Epidemiology, genetics and biochemistry
September 1, 1979

Genetic control of platelet monoamine oxidase activity: studies on normal families,Genetic control of platelet monoamine oxidase activity: Studies on normal families
December 1, 1980

Human platelet monoamine oxidase and the menstrual cycle
December 1, 1980

Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia
January 1, 1980

Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients
January 1, 1980

Platelet monoamine oxidase in families of chronic schizophrenics
January 1, 1980

Platelet monoamine oxidase as a function of nongenetic factors,Platelet Monoamine Oxidase as a Function of Nongenetic Factors
January 1, 1980

Factors affecting determination of platelet monoamine oxidase activity,Factors Affecting Determination of Platelet Monoamine Oxidase Activity
February 1, 1980

Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia
July 1, 1980

Measurement of serum neuroleptic concentrations by radioreceptor assay: concurrent assessment of clinical response and toxicity
February 1, 1981

A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients
October 1, 1981

Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method
April 1, 1981

The schedule for Schizotypal Personalities (SSP): a diagnostic interview for schizotypal features
July 1, 1981

Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication,Platelet Monoamine Oxidase Activity in Acute Schizophrenia: Relationship to Symptomatology and Neuroleptic Medication
June 1, 1981

Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients
September 1, 1981

An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia

Article -

Welcome to inventaire

The library of your friends and communities

You are offline